SCHEMBL989757

SCHEMBL989757

COC1=CCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3728159 0.85
SCHEMBL2218606 0.78
SCHEMBL2070153 0.73
SCHEMBL4809816 0.62
SCHEMBL2050958 0.62
Bromide SCHEMBL28296934 0.61
SCHEMBL2329266 0.61
SCHEMBL7376344 0.60
SCHEMBL10205055 0.58
SCHEMBL12550550 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020121334-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF TIPIRACIL HYDROCHLORIDE AND INTERMEDIATES THEREOF NATCO PHARMA LIMITED (IN) 2020-06-18 WO claimed
WO-2023091726-A1 INHIBITORS OF CYCLIN‑DEPENDENT KINASE 12 (CDK12) SYROS PHARMACEUTICALS, INC. (US) 2023-05-25 WO disclosed
CN-115836063-A Cycloalkylpyrimidines as FERROPORTIN inhibitors 全球血液疗法股份有限公司 2023-03-21 CN disclosed
CN-109996792-B Heterocyclic compounds having activity as modulators of muscarinic M1 and/or M4 receptors in the treatment of CNS diseases and pain 赫普泰雅治疗有限公司 2023-02-17 CN disclosed
CN-114940683-B HPK1 inhibitors and uses thereof 轩竹(北京)医药科技有限公司 2023-01-17 CN disclosed
WO-2020121334-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF TIPIRACIL HYDROCHLORIDE AND INTERMEDIATES THEREOF NATCO PHARMA LIMITED (IN) 2020-06-18 WO disclosed
CN-108003160-B Method for synthesizing [ a ] -cyclized indole derivative 南京理工大学 2020-05-19 CN disclosed
US-8012985-B2 parasiticides, in particularly against Plasmodium and babesia; antimalarial agents CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) 2011-09-06 US disclosed
EP-2275100-A2 Compounds with anti-parasitic activity and drugs containing said compounds Centre National de la Recherche Scientifique (CNRS) (FR) 2011-01-19 EP disclosed
EP-2266555-A2 Compounds with antiparasitic activity and medicines containing same Centre National de la Recherche Scientifique (CNRS) (FR) 2010-12-29 EP disclosed
US-5525731-A CYCLIZATION; HALOGENATION; ALKYLATION; REDUCTION; HYDROLYSIS; DECARBOXYLATION; SELENYLATION SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1996-06-11 US disclosed
US-5446047-A Anticancer agents SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1995-08-29 US disclosed
US-5391745-A Cytotoxic activity towards cancer cells SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1995-02-21 US disclosed
WO-1994011376-A1 CAMPTOTHECIN ANALOGUES AND METHODS OF PREPARATION THEREOF SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1994-05-26 WO disclosed
US-4482557-A 3-Substituted-2-oxo-tetrahydro-pyrrol[1,2-a]pyrimidines having digitalis-like activity CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT. (HU) 1984-11-13 US disclosed
US-4369139-A PREVENTION OF CEREBRAL INSUFFICIENCY HOFFMANN-LA ROCHE INC. (US) 1983-01-18 US disclosed
US-4367229-A 3-Substituted-tetrahydro-pyrrolo[1,2-a]pyrimidines and pharmaceutical compositions CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT. (HU) 1983-01-04 US disclosed
EP-0005143-B1 1-BENZOYL-2-PYRROLIDINONE DERIVATIVE, PROCESSES FOR ITS PREPARATION AND MEDICAMENTS CONTAINING IT F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1982-07-14 EP disclosed
US-4279918-A ANTIDEPRESSANTS, STIMULANTS BYK GULDEN LOMBERG CHEMISCHE FABRIK G.M.B.H. (DE) 1981-07-21 US disclosed
EP-0005143-A1 1-Benzoyl-2-pyrrolidinone derivative, processes for its preparation and medicaments containing it F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1979-11-14 EP disclosed